Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Non Operating Income (2023 - 2026)

Rallybio's Non Operating Income history spans 3 years, with the latest figure at $22.9 million for Q3 2025.

  • On a quarterly basis, Non Operating Income rose 1754.57% to $22.9 million in Q3 2025 year-over-year; TTM through Dec 2025 was $23.2 million, a 5922.81% increase, with the full-year FY2025 number at $22.8 million, up 2960.62% from a year prior.
  • Non Operating Income hit $22.9 million in Q3 2025 for Rallybio, up from $118000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for RLYB hit a ceiling of $22.9 million in Q3 2025 and a floor of -$3.2 million in Q4 2024.
  • Historically, Non Operating Income has averaged $2.2 million across 3 years, with a median of $143000.0 in 2024.
  • The widest YoY moves for Non Operating Income: up 1876.71% in 2024, down 9305.71% in 2024.
  • Tracing RLYB's Non Operating Income over 3 years: stood at $35000.0 in 2023, then crashed by 9305.71% to -$3.2 million in 2024, then skyrocketed by 812.01% to $22.9 million in 2025.
  • Business Quant data shows Non Operating Income for RLYB at $22.9 million in Q3 2025, $118000.0 in Q2 2025, and $174000.0 in Q1 2025.